EDP Biotech News

Follow our progress, be the first to know when ColoPlex™ with marker is available.

ColoPlex Biomarker Data Published in Journal of Clinical Oncology

Abstract. Background: Colorectal cancer (CRC) is the third most common cancer worldwide motivating national screening strategies utilizing fecal immunochemical tests (FIT). Blood-based biomarkers could be an alternative method to increase compliance in population-based screening programs for early detection of CRC. We aimed to identify new blood-based biomarkers that could be potential candidates for use in colorectal cancer screening.

AACC 2022

Want to chat with us during AACC? We want to see you in Chicago. Use the link below to schedule time with EDP during the show.   We'd love to schedule some time to meet you at AACC next week. In attendance will be Eric Mayer, CEO, Jon Dancy our Business Development...

By Abby Kousouris Published: Aug. 17, 2021 at 7:25 PM EDT KNOXVILLE, Tenn. (WVLT) - A local Knoxville company says they’re seeing more demand for COVID-19 testing. EDP Biotech Corporation has different options available for people who want to find out if they have...